Smoking cessation program for LGBTQ+ adults in Arkansas, Oklahoma, Texas
Part of Lungs & breathing clinical trials.
This trial tests whether a program that includes nicotine replacement therapy and volunteering in the LGBTQ+ community helps people quit smoking. You need to live in Arkansas, Oklahoma, or Texas, identify as LGBTQ+, and be ready to quit within 30 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Identify as lesbian, gay, bisexual, transgender, or another sexual or gender minority
- Live in Arkansas, Oklahoma, or Texas
- Smoke cigarettes every day or some days, and have smoked at least 100 cigarettes in your lifetime
- Willing to quit smoking within 30 days of joining the study
- Can read and speak English well or very well
- Have access to the internet at least once a week
- Willing to take part in volunteer activities that serve the LGBTQ+ community
- Own a smartphone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a culturally tailored smartphone app plus coaching to help African American adults quit smoking. You may qualify if you smoke daily, are ready to quit soon, and can use the quit supports they provide.
This study tests a combination of two medicines—varenicline (Chantix) and nicotine lozenges—plus a smartphone app to help people stop smoking. You will be asked to set a quit date within the next week or two and use the app to track your progress for about 6 months.
This study tests a smoking cessation program designed for people who receive care at community behavioral health centers in Chicago. If you're a daily smoker interested in quitting, you may be able to join and get support to help you stop.
This study tests a personalized approach to help Alaska Native and American Indian people quit smoking. You will get treatment based on a blood test, and the study will see if this approach works better than standard care.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This study tests whether nicotine replacement therapy (like patches or gum) can help people living with HIV quit smoking. You'll be part of a program that supports your quit attempt while you receive care for HIV.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.